These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. First Analysis of the Association Between CYP3A4/5, ABCB1 Genetic Polymorphisms and Oxcarbazepine Metabolism and Transport in Chinese Epileptic Patients with Oxcarbazepine Monotherapy and Bitherapy. Wang P; Yin T; Ma HY; Liu DQ; Sheng YA; Zhou BT J Pharm Pharm Sci; 2015; 18(3):256-65. PubMed ID: 26517132 [TBL] [Abstract][Full Text] [Related]
5. Oxcarbazepine: a review of its use in children with epilepsy. Bang L; Goa K Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138 [TBL] [Abstract][Full Text] [Related]
6. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy. Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402 [TBL] [Abstract][Full Text] [Related]
7. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Schmidt D; Elger CE Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112 [TBL] [Abstract][Full Text] [Related]
8. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Mintzer S; Boppana P; Toguri J; DeSantis A Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614 [TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid. Tartara A; Galimberti CA; Manni R; Morini R; Limido G; Gatti G; Bartoli A; Strada G; Perucca E Br J Clin Pharmacol; 1993 Oct; 36(4):366-8. PubMed ID: 12959317 [TBL] [Abstract][Full Text] [Related]
10. Effects of oxcarbazepine and carbamazepine on the central nervous system: computerised analysis of saccadic and smooth-pursuit eye movements. Zaccara G; Gangemi PF; Messori A; Parigi A; Massi S; Valenza T; Monza GC Acta Neurol Scand; 1992 Jun; 85(6):425-9. PubMed ID: 1642114 [TBL] [Abstract][Full Text] [Related]
11. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine. Isojärvi JI; Pakarinen AJ; Rautio A; Pelkonen O; Myllylä VV Epilepsia; 1994; 35(6):1217-20. PubMed ID: 7988514 [TBL] [Abstract][Full Text] [Related]
16. Brain Graph Topology Changes Associated with Anti-Epileptic Drug Use. Haneef Z; Levin HS; Chiang S Brain Connect; 2015 Jun; 5(5):284-91. PubMed ID: 25492633 [TBL] [Abstract][Full Text] [Related]
17. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement. Ross IL; Levitt NS; Van der Walt JS; Schatz DA; Johannsson G; Haarburger DH; Pillay TS Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258 [TBL] [Abstract][Full Text] [Related]
18. Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate. Hirfanoglu T; Serdaroglu A; Camurdan O; Cansu A; Bideci A; Cinaz P; Gucuyener K Pediatr Int; 2007 Dec; 49(6):822-6. PubMed ID: 18045279 [TBL] [Abstract][Full Text] [Related]
19. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency]. Fichna M; Gryczyńska M; Sowińska A; Sowiński J Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518 [TBL] [Abstract][Full Text] [Related]
20. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy. Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]